What is the recommended treatment protocol and drug dosages for a dog with paraplegia caused by tick‑borne fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment Protocol for Canine Paraplegia Due to Tick-Borne Disease

Immediately initiate doxycycline at 10 mg/kg orally twice daily and administer tick antiserum (hyperimmune serum) at 0.5-1.0 mL/kg intravenously for dogs with paraplegia secondary to tick paralysis or tick-borne rickettsial disease.

Critical First Steps

Immediate Tick Removal and Identification

  • Manually remove all attached ticks using fine-tipped forceps, grasping close to the skin and pulling upward with steady pressure 1
  • Search the entire body thoroughly, particularly around the head, neck, and ears
  • The size of the tick does NOT correlate with disease severity 2
  • Do NOT use in situ tick treatments or chemical removal methods—these provide no benefit and delay appropriate therapy 2

Determine the Likely Pathogen

For Australian Paralysis Tick (Ixodes holocyclus):

  • This causes ascending flaccid paralysis from neurotoxin secretion after 72 hours of attachment
  • Mortality rate is approximately 5% with treatment 2
  • Younger dogs have better survival rates 2

For Tick-Borne Rickettsial Diseases (Ehrlichiosis, Anaplasmosis, RMSF):

  • These can cause neurological complications including paraplegia
  • Dogs serve as sentinels for human risk 1
  • Delay in treatment leads to severe disease and death 1

Specific Treatment Protocols

For Australian Tick Paralysis

Primary Therapy:

  • Tick Antiserum (Hyperimmune Serum): 0.5-1.0 mL/kg IV slowly 3, 2
    • Doses above 0.1 mL/kg show no additional benefit 2
    • Subcutaneous administration at tick attachment site is NOT beneficial 2
    • Additional doses in severely affected dogs are associated with WORSE outcomes 2

Adjunctive Therapy:

  • Phenoxybenzamine hydrochloride: Most effective adjunct—all dogs survived in controlled trials when combined with hyperimmune serum 4
    • This alpha-adrenergic blocker attenuates arterial hypertension
    • Specific dosing: consult veterinary critical care protocols

Avoid These Medications:

  • Acepromazine maleate: No benefit on recovery time or mortality 2
  • Dexamethasone: No benefit on recovery time or mortality 2
  • Promethazine hydrochloride: Limited benefit (only 50% survival) 4

For Tick-Borne Rickettsial Diseases (Ehrlichiosis, Anaplasmosis, RMSF)

Doxycycline (Drug of Choice):

  • Dosage: 10 mg/kg (equivalent to 2.2 mg/kg twice daily for dogs <45 kg) orally or IV twice daily 1
  • Duration: Minimum 5-7 days, continue at least 3 days after fever subsides and until clinical improvement 1
  • Route: Oral for stable patients; IV for vomiting, obtunded, or severely ill dogs 1

Expected Response:

  • Fever should subside within 24-48 hours if rickettsial disease 1
  • Lack of response within 48 hours suggests alternative diagnosis or coinfection 1

Alternative Antibiotics (if doxycycline contraindicated):

  • Chloramphenicol for RMSF only (NOT for ehrlichiosis/anaplasmosis) 1
  • Note: Higher mortality risk compared to doxycycline 1

Critical Care Management

Cardiopulmonary Support

  • Address fluid and electrolyte imbalances carefully 1
  • Monitor for vasopressor needs if hypotension develops 1
  • Recognize that respiratory compromise may be due to:
    • Progressive respiratory muscle failure (tick paralysis)
    • Microvascular leakage/ARDS (rickettsial disease) 1

Hospitalization Criteria

  • Respiratory distress or abnormal respiratory scores 2
  • Severe gait abnormalities 2
  • Mental status changes 1
  • Severe thrombocytopenia 1
  • Inability to take oral medications 1

Prognostic Indicators

Good Prognosis:

  • Younger age 2
  • Mild disease at presentation 2
  • Rapid tick removal 2

Poor Prognosis:

  • Severe respiratory or gait scores at presentation 2
  • Delayed treatment initiation 1
  • Need for additional antiserum doses 2

Common Pitfalls to Avoid

  1. Do NOT delay treatment waiting for diagnostic confirmation—empiric therapy must begin immediately based on clinical suspicion 1

  2. Do NOT use prophylactic antibiotics after tick bite in asymptomatic dogs—not supported by evidence 1

  3. Do NOT remove ticks with chemicals, petroleum jelly, or matches—manual removal is superior 1

  4. Do NOT assume inspiratory stridor indicates neck tick attachment—this is not correlated 2

  5. Do NOT increase antiserum doses beyond recommended amounts—no benefit and potential harm 2

  6. Do NOT use chloramphenicol for ehrlichiosis or anaplasmosis—it is ineffective 1

Prevention After Recovery

Highly Effective Preventatives:

  • Isoxazoline class acaricides (fluralaner/Bravecto): 100% efficacy against I. holocyclus for 115+ days 3, 5
  • Oral or topical formulations available 3
  • Low adverse reaction rates 3

Environmental Management:

  • Clip long coats to facilitate tick detection (though this doesn't reduce mortality) 2
  • Daily full-body tick checks 1
  • Avoid tick-infested habitats when possible 1

Monitoring and Follow-Up

  • Dogs treated as outpatients require close monitoring due to potential for rapid decline 1
  • Hospital stay duration averages less when live ticks are manually removed versus other methods 2
  • Recovery time correlates with initial disease severity 2
  • Serologic testing cannot monitor treatment response—antibodies persist for months to years 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.